The legacy of Viagra, and its developer copyright, presents a complex case study for investors. Initially a blockbuster drug, yielding billions in sales , its intellectual property lapse created a flood of generic competition , significantly impacting its dominance. While certain businesses may seek to capitalize on similar conditions , the current